In part 4 this Exclusive Interview, Dr. Hunter Wessells talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of initiating discussions with patients about any urological symptoms they may be experiencing.

In part 5 this Exclusive Interview, Dr. Hunter Wessells answers whether or not sexual dysfunction is inevitably irreversible in a talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 6 of this Exclusive Interview, Dr. Hunter Wessells emphasizes the need for doctors to be aware of the importance of sexual dysfunction information for the sake of their patients. Dr. Wessells talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 7 this Exclusive Interview, Dr. Hunter Wessells talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about common therapies for sexual dysfunction and the need for a study addressing the possible reversal of sexual dysfunction with the management of blood glucose.

We have been following Team NovoNordisk for the past few weeks as they have been in 3 major races. As you can imagine, having consistent accurate readings for the team doctor as they are riding could make a difference. But how would that be possible?  Would it make a big …

Fresh off the Larry H. Miller Tour of Utah and with little time to recover, Team Novo Nordisk tackled the high-altitude Colorado Classic. Team Novo Nordisk's squad included three neo-pros (new professionals), one stagiaire (basically an intern looking for a contract) and two veteran riders, so a very young and fairly inexperienced squad.

In the conclusion of this Exclusive Interview, Dr. Karl Nadolsky shares his treatment philosophy for lowering a patient's A1C down without being too aggressive. Dr. Nadolsky talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas.

In this week's Homerun Slides, the conclusion of Dr. Stanley Schwartz's presentation on the beta-cell classification of diabetes and delaying the need for insulin.

It was a challenge to develop a computer model that could account for plasma dynamics in a compact but accurate package. The model was the simplest representation we could devise, which was based upon known physiology, and which could accurately describe moment-by-moment plasma dynamics. The model continues to thrive in that it continues to be the basis for a large number of clinical investigations (∼50 per year) as well as a robust literature related to its mathematical and computer characteristics

Years ago the number one reason to try something new in diabetes was to benefit the patient. This is what led to new insulins, oral medications and devices like insulin pumps and continuous glucose monitors. All was going well till the PBM’s got involved. Now it all about what is …